Dry eyes : a commonly missed eye condition by Vella, Mario
t ears are an important component in providing moisture and lubrication for the eyes, thereby maintaining vision and comfort. The tear film itself is made up of three components: 
 
1. The outermost oily layer is produced by the meibomian 
glands which line the edge of the eyelids and produce 
lubrication. These smooth the tear surface and slow 
evaporation of the middle watery layer. If these glands 
don’t produce enough oil, the watery layer evaporates 
too quickly, causing dry eyes. Dry eyes are common in 
people whose meibomian glands are clogged. Meibomian 
dysfunction is more common in people with inflammation 
along the edge of their eyelids (blepharitis), rosacea and 
other skin disorders.
2. The watery portion of the tear film is produced by the 
lacrimal gland. This gland lies just below the eyebrow 
under the superior outer orbital rim and it produces 
moisture. This watery layer cleanses the eyes and washes 
away foreign particles or irritants. If the eye produces 
inadequate amounts of water, the oil and mucous layers 
can touch and cause a stringy discharge. 
3. The mucous layer comes from microscopic goblet cells 
in the conjunctiva and these contribute to the even 
spreading of the tear film.If the eyes do not produce 
enough mucus to cover the eyes, dry spots can form on the 
cornea.
With each blink the tear film is spread evenly across the 
surface of the cornea. The blinking motion of the eyelids forces 
the tears through the medial puncta into the upper and lower 
canaliculus, which empty into the lacrimal sac. The lacrimal sac 
drains into the nasolacrimal duct which connects to the nasal 
passage.
Dry eyes (keratoconjunctivitis sicca) result when there is 
either decreased production of tears  or by poor tear quality 
which in turn lead to more rapid evaporation. The presenting 
symptoms in evaporative dry eyes are burning and foreign body 
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sensation, sensitivity to light, and eye fatigue.  The signs are 
redness, blurred vision, often worsening at the end of the day 
or after focusing for a prolonged period of time and excessive 
tearing. Patients find it difficult to understand how excessive 
tearing is a result of dry eyes. Tears produced which are of poor 
quality  tend to dry off quickly and there is also an uneven 
spread of the tears leading to dry patches on the cornea. This  
leads to a vicious cycle and overproduction of tears. 
Factors which make it more likely for a patient to develop 
dry eyes are:
•	 Age older than 50 years. It is a known fact that as we grow 
older the production of tears diminishes. 
•	 Post-menopausal women. This may be due in part to 
hormonal changes.
•	 Medical conditions associated with decreased production 
of tears, like diabetes, rheumatoid arthritis, lupus, 
scleroderma, Sjogren’s syndrome, thyroid disorders and 
vitamin A deficiency.
•	 Tear gland damage. Damage to the tear glands from 
inflammation or radiation can hamper tear production.
•	 Corrective laser eye surgery. Refractive eye surgery may 
cause decreased tear production and dry eyes. Symptoms 
of dry eyes related to these procedures are usually 
temporary.
•	 Eyelid problems. If there is an eyelid problem that makes 
it difficult to blink, tears may not be spread across the eye 
adequately or tears may evaporate too quickly, causing dry 
eyes. Eyelid problems can include an out-turning of the 
lids (ectropion) or an in-turning of the lids (entropion). 
Medications that can cause dry eyes include: 
•	 Some drugs used to treat high blood pressure, example, 
propranolol, prazosin and atenolol 
•	 Antihistamines and decongestants, example, cetirizine and 
loratadine 
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•	 Hormone replacement therapy 
•	 Certain antidepressants example, 
amitriptyline, promethazine and 
thioridazine 
•	 Isotretinoin-type drugs for 
treatment of acne 
Other causes of dry eyes include: 
•	 Wind 
•	 Dry air 
•	 Tasks that require enough concentration that 
you blink less often, such as working 
at a computer, driving or reading. 
In all these actions the blink rate is 
less, as patients tend to “stare” more 
concentrating on the task at hand.
The consequences of dry eyes may result 
in a decreased quality of life as everyday tasks 
become difficult especially in the severely 
affected. The tears also protect the surface 
of the eye and the integrity of the corneal 
epithelium and any problems with this may 
lead to an increased risk of eye infection. Dry 
eyes may lead to chronic inflammation and in severe cases may 
even lead to corneal surface scarring and problems with vision.
Like any other ophthalmic condition, taking a good history 
including a drug history is important in reaching a diagnosis. 
The production of tears may be assessed by the Schirmer. In this 
test, blotting strips of paper are placed under the lower eyelids 
of each eye. After five minutes the doctor measures the amount 
of strip which has been moistened with the tears. A much 
simpler and more widely used test is the tear break-up time 
(TBUT). Here one needs to instill sodium fluorescein solution 
in the eye, then the patient is asked not to blink and the doctor 
counts the seconds until dry patches appear on the cornea 
meaning that the fluorescein film starts to break up without 
blinking. Normally this takes about 15 seconds in normal 
individuals; any result under 10 seconds is a strong indicator of 
dry eyes.
The main treatment of dry eyes is the administration of 
lubricating drops, and when started these should be continued 
for a minimum period of four weeks. Simple lubricating drops 
are usually recommended; it is advisable to avoid lubricating 
drops which contain vasoconstrictors as when the latter 
are stopped there tends to be a rebound phenomenon with 
recurrence of the red eye. The role of the lubricating drops 
are to increase the tear film stability; the idea is to restore the 
natural homeostasis of the ocular surface and tear film and to 
improve the patient’s ocular comfort and quality of life. There 
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is a wide range of products available and it 
is up to the doctor or the ophthalmologist 
to choose one that is best for the patient. 
Lubricating drops are safe to use long-
term and can come with or without 
preservatives. In some cases where the 
patient is producing normal tears but 
the quantity is not enough, blocking the 
lacrimal duct is sometimes used. The lacrimal 
ducts may be blocked temporarily with collagen 
plugs which dissolve over a few weeks or more 
permanently with silicone plugs or cauthery, 
although the latter is rarely indicated. The 
puncta of the lower eyelid are blocked first 
as these drain over 70% of the tears into 
the nasal cavity.
It is important to remember that dry eyes 
are a very common problem that can affect 
anywhere between 5 to 35% of the population. 
Lubricating drops are still considered to be 
the main treatment as they provide a safe 
and effective way of treatment  and provide 
symptomatic relief to patients.  
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